This study demonstrates for the first time that ZNF582-AS1 functions as a tumor suppressor gene in ccRCC and ZNF582-AS1 may serve as a potential biomarker and therapeutic target of ccRCC. The gene discussed is ZNF582; the disease is nonpapillary renal cell carcinoma.